Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.
  • Eventos
  • Noticias
  • Análisis
  • Cuenta
Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

News

Categories

  • Últimas
  • Agricultura
  • Cadena de Suministro
  • China y BRICS+
  • Ciberseguridad
  • Defensa
  • Energía y Movilidad
  • Fintech
  • IA y Tecnología
  • Robótica
  • Salud
  • Semiconductores
  • Startups y Capital Riesgo

Select a category to explore the latest industry reporting.

NewsWednesday, 26 August 2026
Newsletter subscribe · Free
  • Últimas
  • IA y Tecnología
  • Ciberseguridad
  • Semiconductores
  • Robótica
  • Fintech
  • Energía y Movilidad
  • Defensa
  • Salud
  • Cadena de Suministro
  • Startups y Capital Riesgo
  • China y BRICS+
  • Agricultura

Noticias

Salud

Las últimas noticias, anuncios y análisis del sector Salud, provenientes de las conferencias, exposiciones y cumbres que dan forma al sector.

Últimas noticias de la sección

STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients (opens original source in a new tab)
STAT News

STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients

Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

Sanofi is experiencing shortages of two medicines for Pompe disease, alarming patient groups.

(opens original source in a new tab)
Ed Silverman·10 August 2026
Opinion: Fauci doesn’t have the answers on Covid’s origins. China does (opens original source in a new tab)
STAT News

Opinion: Fauci doesn’t have the answers on Covid’s origins. China does

“To blame Fauci for not solving the origin of Covid-19 makes as much sense as blaming a detective in Washington, D.C., for not solving a murder in Wuhan,” writes David…

(opens original source in a new tab)
David J. Hunter·7 August 2026
STAT+: Up and down the ladder: The latest comings and goings (opens original source in a new tab)
STAT News

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

(opens original source in a new tab)
Ed Silverman·7 August 2026
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue (opens original source in a new tab)
STAT News

STAT+: NIH plans to block international researchers on visas from accessing key funding avenue

The NIH plans to close the door on one of the few pathways available to international students on visas to forge a career in biomedical research in the U.S.

(opens original source in a new tab)
Anil Oza·7 August 2026
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more

Eli Lilly and Novo Nordisk convinced a federal judge to toss an antitrust lawsuit by a compound pharmacy

(opens original source in a new tab)
Ed Silverman·7 August 2026
Is the biotech capital of the world moving? (opens original source in a new tab)
STAT News

Is the biotech capital of the world moving?

Replimune finally wins FDA approval, the role of tau in Alzheimer's, and more biotech news from The Readout

(opens original source in a new tab)
Meghana Keshavan·7 August 2026
A third clinic settles with DOJ over trans care (opens original source in a new tab)
STAT News

A third clinic settles with DOJ over trans care

Anthony Fauci held in contempt, crackdowns on the organ donor network, and more health news from Morning Rounds

(opens original source in a new tab)
O. Rose Broderick·7 August 2026
STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California? (opens original source in a new tab)
STAT News

STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?

Boston, with its rising costs, high taxes, and business climate, is losing ground to rivals across the country, sometimes even in biotech.

(opens original source in a new tab)
Emma Platoff — Boston Globe·7 August 2026
Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack (opens original source in a new tab)
STAT News

Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack

“It was briefly more dangerous to sit at a desk in Atlanta than to chase a hemorrhagic fever in the field,” writes Daniel Jernigan.

(opens original source in a new tab)
Daniel Jernigan·7 August 2026
Opinion: AI won’t enhance physician autonomy. It will further diminish it (opens original source in a new tab)
STAT News

Opinion: AI won’t enhance physician autonomy. It will further diminish it

“AI is not the villain here; it is a mirror,” reflecting the diminishment of physician judgment, writes former surgeon Frances Mei Hardin.

(opens original source in a new tab)
Frances Mei Hardin·7 August 2026
STAT+: FDA approves Replimune melanoma drug previously rejected twice (opens original source in a new tab)
STAT News

STAT+: FDA approves Replimune melanoma drug previously rejected twice

The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.

(opens original source in a new tab)
Elaine Chen·6 August 2026
STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts (opens original source in a new tab)
STAT News

STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts

A little-noticed government policy shift caused a seven-year delay in choosing a costly medicine for Medicare price negotiations, an advocacy group says.

(opens original source in a new tab)
Ed Silverman·6 August 2026

Los más leídos

  1. 01

    STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients

  2. 02

    Opinion: Fauci doesn’t have the answers on Covid’s origins. China does

  3. 03

    STAT+: Up and down the ladder: The latest comings and goings

  4. 04

    STAT+: NIH plans to block international researchers on visas from accessing key funding avenue

  5. 05

    STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more

Prev
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
Next
  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

La semana en eventos de la industria, entregada cada viernes.

Un email corto. Las mejores historias de ferias, conferencias y cumbres que dan forma a los negocios mundiales. Sin relleno, sin spam, cancela en cualquier momento.